Diabetic neuropathy is a major driver of the India neuropathic pain market. India has a large and growing population with diabetes, increasing the need for early diagnosis, pain management, and long-term monitoring. The market was valued at USD 487.5 million in 2024 and is projected to reach approximately USD 1.04 billion by 2035 at a CAGR of around 7.11%. Rising diabetes and nerve-related...